Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure

AIMS: Patients suffering from chronic ischaemic heart failure with reduced left ventricular ejection fraction (HFrEF) have reduced quality‐of‐life, repetitive hospital admissions, and reduced life expectancy. Allogeneic cell therapy is currently investigated as a potential treatment option after ini...

Descripción completa

Detalles Bibliográficos
Autores principales: Qayyum, Abbas Ali, Mouridsen, Mette, Nilsson, Brian, Gustafsson, Ida, Schou, Morten, Nielsen, Olav Wendelboe, Hove, Jens Dahlgaard, Mathiasen, Anders Bruun, Jørgensen, Erik, Helqvist, Steffen, Joshi, Francis Richard, Johansen, Ellen Mønsted, Follin, Bjarke, Juhl, Morten, Højgaard, Lisbeth Drozd, Haack‐Sørensen, Mandana, Ekblond, Annette, Kastrup, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053281/
https://www.ncbi.nlm.nih.gov/pubmed/36638837
http://dx.doi.org/10.1002/ehf2.14281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053281/
https://www.ncbi.nlm.nih.gov/pubmed/36638837
http://dx.doi.org/10.1002/ehf2.14281

Ejemplares similares